1.31
price down icon2.96%   -0.04
after-market Handel nachbörslich: 1.28 -0.03 -2.29%
loading
Schlusskurs vom Vortag:
$1.35
Offen:
$1.32
24-Stunden-Volumen:
148.17K
Relative Volume:
0.25
Marktkapitalisierung:
$1.93M
Einnahmen:
$502.40K
Nettoeinkommen (Verlust:
$-7.91M
KGV:
-0.1314
EPS:
-9.972
Netto-Cashflow:
$-4.32M
1W Leistung:
-0.76%
1M Leistung:
-39.49%
6M Leistung:
-55.67%
1J Leistung:
-80.30%
1-Tages-Spanne:
Value
$1.24
$1.37
1-Wochen-Bereich:
Value
$1.24
$1.40
52-Wochen-Spanne:
Value
$1.24
$12.70

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
Firmenname
60 Degrees Pharmaceuticals Inc
Name
Telefon
202-327-5422
Name
Adresse
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
Mitarbeiter
3
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SXTP's Discussions on Twitter

Vergleichen Sie SXTP mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
SXTP
60 Degrees Pharmaceuticals Inc
1.31 4.36M 502.40K -7.91M -4.32M -9.972
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
390.30 99.42B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
565.97 58.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
442.73 56.35B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
652.43 39.02B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
309.69 34.25B 3.81B -644.79M -669.77M -6.24

60 Degrees Pharmaceuticals Inc Aktie (SXTP) Neueste Nachrichten

pulisher
07:44 AM

What’s the recovery path for long term holders of 60 Degrees Pharmaceuticals Inc.Volume Spike & Pattern Based Trade Signal System - Newser

07:44 AM
pulisher
07:33 AM

Is 60 Degrees Pharmaceuticals Inc. still a buy after recent gainsMarket Activity Report & AI Based Buy/Sell Signal Reports - 선데이타임즈

07:33 AM
pulisher
06:32 AM

Sector ETF performance correlation with 60 Degrees Pharmaceuticals Inc. Equity WarrantDip Buying & Safe Swing Trade Setups - Newser

06:32 AM
pulisher
06:08 AM

Will 60 Degrees Pharmaceuticals Inc. Equity Warrant benefit from macro trendsTrade Performance Summary & High Win Rate Trade Alerts - Newser

06:08 AM
pulisher
05:56 AM

Published on: 2025-08-14 04:56:03 - Newser

05:56 AM
pulisher
05:41 AM

Should you hold or exit 60 Degrees Pharmaceuticals Inc. nowTrade Volume Summary & AI Enhanced Trading Alerts - Newser

05:41 AM
pulisher
04:24 AM

Tick level data insight on 60 Degrees Pharmaceuticals Inc. Equity Warrant volatilityJuly 2025 Sentiment & Scalable Portfolio Growth Ideas - Newser

04:24 AM
pulisher
03:39 AM

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant rally from current levelsJuly 2025 Reactions & Daily Profit Focused Stock Screening - Newser

03:39 AM
pulisher
02:43 AM

What makes 60 Degrees Pharmaceuticals Inc. Equity Warrant stock price move sharply2025 Support & Resistance & Consistent Profit Alerts - Newser

02:43 AM
pulisher
02:34 AM

Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc. Equity WarrantWall Street Watch & Free Community Supported Trade Ideas - Newser

02:34 AM
pulisher
01:03 AM

Published on: 2025-08-14 00:03:25 - Newser

01:03 AM
pulisher
12:37 PM

60 Degrees Pharmaceuticals Reports Q2 2025 Earnings - TipRanks

12:37 PM
pulisher
Aug 13, 2025

60 Degrees Pharmaceuticals Inc. Equity Warrant stock trend outlook and recovery pathMarket Volume Report & Daily Entry Point Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What momentum shifts mean for 60 Degrees Pharmaceuticals Inc. Equity WarrantPortfolio Profit Report & High Win Rate Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

60 Degrees Pharmaceuticals' Earnings Woes: A Microcosm of Small-Cap Biotech's Struggles and Hopes - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results - The Manila Times

Aug 13, 2025
pulisher
Aug 13, 2025

60 Degrees Pharmaceuticals Reports Q2 2025 Financial Results: Revenue Decline Due to Supply Disruption, Increased Profitability from Cash-Pay Model - Quiver Quantitative

Aug 13, 2025
pulisher
Aug 13, 2025

60 Degrees Pharma Reveals $1.1B Market Opportunity Despite Q2 Revenue Drop - Stock Titan

Aug 13, 2025
pulisher
Aug 13, 2025

60 DEGREES PHARMACEUTICALS, INC. SEC 10-Q Report - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Reversal indicators forming on 60 Degrees Pharmaceuticals Inc. Equity Warrant stockTrade Risk Assessment & Fast Gain Stock Tips - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Using economic indicators to assess 60 Degrees Pharmaceuticals Inc. potentialPortfolio Growth Summary & Stock Timing and Entry Methods - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Long term hold vs stop loss in 60 Degrees Pharmaceuticals Inc. Equity WarrantMarket Volume Report & Capital Efficient Trade Techniques - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Using flow based indicators on 60 Degrees Pharmaceuticals Inc.Weekly Investment Report & Community Verified Swing Trade Signals - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

60 Degrees Pharmaceuticals Inc. Equity Warrant stock trendline breakdown2025 EndofYear Setup & High Conviction Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How sentiment analysis helps forecast 60 Degrees Pharmaceuticals Inc.Earnings Beat & Reliable Trade Execution Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What Fibonacci levels say about 60 Degrees Pharmaceuticals Inc. reboundWeekly Trade Review & Safe Entry Trade Signal Reports - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Applying big data sentiment scoring on 60 Degrees Pharmaceuticals Inc. [Market Trend Summary]Free Long Hold Capital Preservation Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What makes 60 Degrees Pharmaceuticals Inc. stock price move sharplyMarket Growth Report & Low Volatility Stock Recommendations - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Published on: 2025-08-13 00:13:33 - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Has 60 Degrees Pharmaceuticals Inc. found a price floorAI Model Forecasting Reversal and Breakout Zones - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Published on: 2025-08-12 23:41:59 - 선데이타임즈

Aug 12, 2025
pulisher
Aug 12, 2025

Can 60 Degrees Pharmaceuticals Inc. Equity Warrant recover in the next quarterFree Growth Based Investment Plan Guidance - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What technical models suggest about 60 Degrees Pharmaceuticals Inc. Equity Warrant’s comebackTrend Reversal Probability Forecast Update - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

What to do if you’re stuck in 60 Degrees Pharmaceuticals Inc. Equity WarrantFree Alert Feed for Momentum Based Picks - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Applying big data sentiment scoring on 60 Degrees Pharmaceuticals Inc.Smart Money Strategy for Growth Stocks - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

What technical models suggest about 60 Degrees Pharmaceuticals Inc.’s comebackBreakout Screener With Alert Based Timing - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Is a relief rally coming for 60 Degrees Pharmaceuticals Inc. Equity Warrant holdersFree High Yield Stocks With Buy Confirmation - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

60 Degrees Pharmaceuticals (SXTP) to Release Earnings on Wednesday - Defense World

Aug 11, 2025
pulisher
Aug 11, 2025

Is 60 Degrees Pharmaceuticals Inc. Equity Warrant a candidate for recovery playPortfolio Review Summary with Five-Year Outlook - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Visual trend scoring systems applied to 60 Degrees Pharmaceuticals Inc. Equity WarrantFree Consistent Gain Investment Strategies - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Historical volatility pattern of 60 Degrees Pharmaceuticals Inc. Equity Warrant visualizedFree Expert Verified Stock Trade Ideas - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Can trapped investors hope for a rebound in 60 Degrees Pharmaceuticals Inc.Predictive Screener for Daily Trade Watch - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What moving averages say about 60 Degrees Pharmaceuticals Inc. Equity WarrantTechnical Insight Guide for Safer Trades - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Using fundamentals and technicals on 60 Degrees Pharmaceuticals Inc.Free Fast Return Equity Trade Forecast - Newser

Aug 10, 2025

Finanzdaten der 60 Degrees Pharmaceuticals Inc-Aktie (SXTP)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

60 Degrees Pharmaceuticals Inc-Aktie (SXTP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
XU CHERYL
Director
Dec 13 '24
Buy
1.56
6,000
9,375
52,078
XU CHERYL
Director
Dec 12 '24
Buy
1.82
5,000
9,125
46,078
XU CHERYL
Director
Dec 16 '24
Buy
1.45
2,000
2,900
54,078
DOW GEOFFREY S
President and CEO
Dec 09 '24
Buy
1.27
35,823
45,563
94,580
DOW GEOFFREY S
President and CEO
Dec 06 '24
Buy
1.20
20,579
24,672
58,757
DOW GEOFFREY S
President and CEO
Dec 05 '24
Buy
1.11
17,549
19,520
38,178
DOW GEOFFREY S
President and CEO
Nov 21 '24
Buy
0.91
3,500
3,195
20,629
DOW GEOFFREY S
President and CEO
Nov 19 '24
Buy
0.90
2,500
2,248
16,129
DOW GEOFFREY S
President and CEO
Nov 20 '24
Buy
0.92
1,000
924
17,129
XU CHERYL
Director
Aug 27 '24
Buy
1.70
5,000
8,500
41,078
$36.50
price up icon 0.11%
$86.16
price up icon 0.36%
$26.45
price down icon 1.56%
$127.75
price up icon 3.97%
$112.70
price down icon 0.07%
biotechnology ONC
$309.69
price up icon 0.71%
Kapitalisierung:     |  Volumen (24h):